Market Summary | Major Indices | Market Movers | Market Sectors | Mutual Funds | A-Z Stock Listings
ETF Screener | World Markets | Currencies | CEO Wealthmeter | Oil / Energy | Metals
Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
PAIN THERAPEUTICS Add to My Watchlist (NSDQ: PTIE) 
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     Pain 5.53 -0.03 (-0.54%) 33,882
2211 Bridgepointe Parkway
Suite 500
San Mateo, CA 94404 US
(650) 624-8200
(650) 624-8222 fax
www.paintrials.com
CEO Remi Barbier
Auditor Ernst & Young LLP
Exchange Traded NQ
ISIN Number US69562K1007
CIK Number 1069530
NAICS Code 325412
Business Summary
A biopharmaceutical Company that develops novel drugs. It has four drug candidates in clinical programs, including Remoxy, Oxytrex, PTI-202 and a novel radio-labeled monoclonal antibody to treat metastatic melanoma.
Number of Employees 27
Share Fundamentals
Market Cap 233.93M
Shares Outstanding 42.30M
Float 35.00M
Short Interest 1.66M
Financial Strength
Revenue (TTM) $20,563,000
Earnings (TTM) -$3,467,000
Quick Ratio 9.5:1
Current Ratio 9.6:1
Total Debt/Equity 0:1
Profitability
Gross Margin N/A
EBITDA Margin -31.6%
Profit Margin -24.2%
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Stock Updates provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs